EUCTR2012-005617-39-DE进行中（未招募）1 期
Pharmacokinetics of Tigecycline in Patients Receiving Continuous Renal Replacement Therapy
niversity Hospital Tuebingen0 个研究点目标入组 16 人开始时间: 2013年12月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •* Male and female patients
- •* Indication for Tigecycline therapy based on suspected/diagnosed infection
- •* Patients with acute renal failure and renal replacement therapy (CVVHD of CVVHDF)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 6
排除标准
- •* Pregnant women
- •* breastfeeding mother
- •* Age > 75 years
- •* liver failure
- •* Comedication with warfarin
- •* Known allergies to antibiotics of the tetracycline group
研究者
相似试验
已完成
不适用
Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)DiarrheaClostridium DifficileNCT01401023Gary E. Stein, Pharm.D.10
尚未招募
不适用
Pharmacokinetics of intravenous tigecycline in pediatric patientsPK parameters of tigecycline in pediatric patients with multidrug-resistant infection receiving intravenous tigecyclineTigecycline, Pharmacokinetics, Multidrug-resistant resistant organisms, PediatricsTCTR20240319006Ratchadapisek Sompoch Research Fund12
Unknown
不适用
Population Pharmacokinetics of Tigecycline in Patients Treated With ECMOExtracorporeal Membrane OxygenationPharmacokineticsTigecyclineNCT04724798Nanfang Hospital, Southern Medical University10
Unknown
不适用
Study of Tigecycline Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy(CRRT)Critically IllBacterial InfectionNCT02931526Zhujiang Hospital20
已完成
1 期
Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary CirrhosisLiver Cirrhosis, BiliaryNCT00406237Wyeth is now a wholly owned subsidiary of Pfizer8